Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 25,190 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PRE Clear all

Conditions: Leg Cramp, Nocturnal
Interventions: Theraworx, Placebo; Device · Other
Lead sponsor: Sport and Spine Rehab Clinical Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Type 2 Diabetes Mellitus, Impaired Glucose Tolerance
Interventions: Canakinumab 150 mg, Placebo to Canakinumab; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 11
States / cities: Los Angeles, California • Santa Ana, California • Spring Valley, California + 7 more

Conditions: Postoperative Ecchymosis
Interventions: DDAVP; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Lyndhurst, Ohio

Conditions: Congenital Heart Disease
Interventions: 3D model of heart; Other
Lead sponsor: Columbia University; Other
Eligibility: Not listed
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 6
States / cities: Palo Alto, California • Gainesville, Florida • Atlanta, Georgia + 2 more

Conditions: Acute Myeloid Leukemia, Adult, Acute Myeloid Leukemia Recurrent, Acute Myeloid Leukemia, Relapsed, Adult
Interventions: Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO); Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Dysphagia
Interventions: Proactive pharyngeal-laryngeal Exercise Program, Premier Protein Clear ® High Protein, Hydration Counseling; Behavioral · Dietary Supplement
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 99 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer of Prostate
Interventions: ADT ORDER CHECK ATTESTATION (OR), PROVIDER SCRIPT (SC); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Dementia Alzheimer's Type
Interventions: SAR110894, placebo (for SAR110894), Donepezil; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 55 Years and older
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 27
States / cities: Gilbert, Arizona • Phoenix, Arizona • Costa Mesa, California + 24 more

Conditions: Endothelial Dysfunction
Interventions: Climara, Placebo patch, Resveratrol, Placebo; Drug · Dietary Supplement
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 50 Years to 70 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Blood Cancer, Leukemia
Interventions: Cyclosporine, Anti-thymocyte globulin (ATG), Mycophenolate mofetil (MMF), Filgrastim, Total Lymphoid Irradiation (TLI); Drug · Radiation
Lead sponsor: Stanford University; Other
Eligibility: 50 Years to 70 Years
Enrollment: 303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2016
U.S. locations: 1
States / cities: Stanford, California

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: LEADing Dementia End-of-Life Planning Conversations; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Lung Cancer, Non-small Cell Lung Cancer
Interventions: Vorinostat, Pembrolizumab; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Chronic Pain
Interventions: Acupuncture, myofascial therapy, microcurrent therapy, LASER, extracorporeal shockwave therapy, Pulsed electromagnetic therapies, Miscellaneous integrative medicine; Other
Lead sponsor: David Moss; Federal
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Nellis Air Force Base, Nevada

Conditions: Eye Infections, Postoperative Complications
Interventions: Prednisolone and Tobramycin, Prednisolone; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 6
States / cities: Great Bend, Kansas • Boston, Massachusetts • Saint Joseph, Michigan + 3 more

Conditions: Multiple Myeloma
Interventions: Propranolol; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 75 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Colorectal Disorders
Interventions: Exparel, IV Lidocaine; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 75 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Sexual Behavior, Hypoxia, Brain
Interventions: Partnered sex involving choking, Partnered sex not involving choking; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 30 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Dysmenorrhea, Headache, Migraine, Fatigue, Nausea, Mood Disturbance
Interventions: Pure Femme Tablets; Drug
Lead sponsor: Pure Green; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Sterling Heights, Michigan

Conditions: Skin Laxity
Interventions: Percutaneous Radiofrequency single treatment; Device
Lead sponsor: ThermiGen, LLC; Industry
Eligibility: 35 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Montclair, New Jersey

Conditions: Dental Pain
Interventions: Pre-Op pregabalin, Pre-Op Placebo 1, Post-Op pregabalin, Post-Op Placebo 1, Post-Op Placebo 2, Post-Op acetaminophen; Drug
Lead sponsor: Nevakar, Inc.; Industry
Eligibility: 17 Years to 55 Years
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Pancreatic Adenocarcinoma
Interventions: 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT, Computed Tomography, Positron Emission Tomography, Laboratory Biomarker Analysis; Drug · Procedure · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hip Injuries, Fractures, Hip, Fall Injury, Fall Risk, Osteoporosis, Osteoporosis Risk
Interventions: Tango Belt, Standard of Care (SOC); Device · Other
Lead sponsor: ActiveProtective Technologies, Inc; Industry
Eligibility: 65 Years and older
Enrollment: 471 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 10
States / cities: Sacramento, California • Bensalem, Pennsylvania • Gwynedd, Pennsylvania + 7 more

Conditions: Malaria
Interventions: Mefloquine, Control; Drug · Other
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Silver Spring, Maryland

Conditions: Pregnancy Related, Pelvic Floor Disorders, Obstetric; Injury, Patient Empowerment
Interventions: Pelvic wand; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Effect of Theraworx/[pH]Uel on Night-time Leg Cramps and Spasm Symptoms

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies

DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty

Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Anterior Cervical Discectomy and Fusion (ACDF) - Behavioral Intervention

De-implementation of Low Value Castration for Men With Prostate Cancer

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

LEADing Dementia End-of-Life Planning Conversations

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Prospective Assessment of Integrative Therapies for Neuromusculoskeletal Pain (PAIN)

A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte

Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients

Pain Control in Colorectal Surgery: Liposomal Bupivacaine Block Versus Intravenous Lidociane

Uncovering the Acute Neurobiological Significance of Emerging Sexual Behaviors

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

Safety and Effectiveness Evaluation of the Device in Achieving Submental Lift

Dental Pain Study of Analgesics in Patients Undergoing Molar Removal

Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma

Mitigation of Major Hip Injury Due to Fall With a Smart Belt

Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection

Perineal Massage Using A Pelvic Wand During Pregnancy